Published in NIPH Ann on December 01, 1983
Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting. Infect Immun (1986) 1.94
Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection. J Clin Microbiol (1988) 1.34
Human immunoglobulin G subclass immune response to outer membrane antigens in meningococcal group B vaccine. J Clin Microbiol (1987) 1.17
Development of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse model. Infect Immun (1984) 1.11
Human opsonins to meningococci after vaccination. Infect Immun (1984) 0.88
Immune responses in mice to different noncovalent complexes of meningococcal B polysaccharide and outer membrane proteins. Infect Immun (1988) 0.81
Meningococcal disease in Canada: surveillance summary to 1987. CMAJ (1989) 0.78
A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem (1982) 36.39
Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis (1985) 6.62
Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet (1991) 6.26
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med (2001) 5.50
Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci U S A (1986) 5.39
Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J Bacteriol (1987) 5.30
Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers. J Gen Microbiol (1986) 5.05
Classification of Neisseria meningitidis group B into distinct serotypes. I. Serological typing by a microbactericidal method. Infect Immun (1972) 4.96
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol (1994) 4.95
An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity. J Exp Med (1974) 4.90
Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group. Clin Diagn Lab Immunol (1997) 4.65
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA (1999) 3.69
Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis (1989) 3.66
Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (2001) 3.29
Classification of Neisseria meningitidis group B into distinct serotypes. 3. Application of a new bactericidal-inhibition technique to distribution of serotypes among cases and carriers. J Infect Dis (1973) 3.17
Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet (1994) 3.16
Natural competence in the genus Streptococcus: evidence that streptococci can change pherotype by interspecies recombinational exchanges. J Bacteriol (1997) 2.86
Identification of the streptococcal competence-pheromone receptor. Mol Microbiol (1996) 2.85
Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model. J Exp Med (1978) 2.85
Classification of Neisseria meningitidis group B into distinct serotypes. II. Extraction of type-specific antigens for serotyping by precipitin techniques. Infect Immun (1972) 2.80
Strain-specific variation in the protein and lipopolysaccharide composition of the group B meningococcal outer membrane. J Bacteriol (1976) 2.79
Meningococcal serotypes and serogroup B disease in north-west Europe. Lancet (1986) 2.76
Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J Clin Microbiol (1992) 2.67
Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol (1994) 2.63
Circulating N-terminal pro-atrial natriuretic peptide is an independent predictor of left ventricular hypertrophy in the general population. The Tromsø Study. Eur Heart J (1999) 2.59
Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA. J Med Microbiol (1990) 2.58
Detection of Legionella pneumonophila antigen in urine by enzyme-linked immunospecific assay. J Clin Microbiol (1979) 2.54
Five structural classes of major outer membrane proteins in Neisseria meningitidis. J Bacteriol (1981) 2.48
Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect Immun (1995) 2.44
Serogroup identification of Neisseria meningitidis: comparison of an antiserum agar method with bacterial slide agglutination. J Clin Microbiol (1978) 2.44
Deadly relic of the Great War. Nature (1998) 2.41
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect (2011) 2.38
Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978. J Clin Microbiol (1979) 2.23
Identification of DNA binding sites for ComE, a key regulator of natural competence in Streptococcus pneumoniae. Mol Microbiol (1999) 2.18
Gelatin neutralization of the inhibitory effect of sodium polyanethol sulfonate on Neisseria meningitidis in blood culture media. J Clin Microbiol (1977) 2.16
Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers. Infect Immun (1988) 2.14
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother (2013) 2.14
Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann (1991) 2.13
Bacterial antigen detection in body fluids: methods for rapid antigen concentration and reduction of nonspecific reactions. J Clin Microbiol (1980) 2.13
Evaluation of previously assigned antibody concentrations in pneumococcal polysaccharide reference serum 89SF by the method of cross-standardization. Clin Diagn Lab Immunol (1998) 2.12
Natural competence for genetic transformation in Campylobacter pylori. J Infect Dis (1990) 2.06
Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal epithelial cells. J Infect Dis (1980) 2.05
Genetic relationships and clonal population structure of serotype 2 strains of Neisseria meningitidis. Infect Immun (1987) 2.04
Heterogeneity and variation among Neisseria meningitidis lipopolysaccharides. J Bacteriol (1983) 2.01
[Human "Yersinia enterocolitica" septicemia. 17 recent cases]. Presse Med (1971) 2.01
Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation (1997) 2.00
An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study. J Clin Microbiol (2000) 1.97
Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect Immun (1994) 1.96
Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986. J Infect Dis (1990) 1.96
Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens. Infect Immun (1982) 1.96
Heat-modifiable outer membrane proteins of Neisseria meningitidis and their organization within the membrane. J Bacteriol (1978) 1.95
Chemical analysis of major outer membrane proteins of Neisseria meningitidis: comparison of serotypes 2 and 11. J Bacteriol (1980) 1.95
[Clinical manifestations caused by group A streptococci]. Tidsskr Nor Laegeforen (1990) 1.95
Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting. Infect Immun (1986) 1.94
Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis (1990) 1.91
An outbreak of group B meningococcal disease: tracing the causative strain of Neisseria meningitidis by DNA fingerprinting. J Clin Microbiol (1986) 1.88
The importance of blood volume cultured on detection of bacteraemia. Acta Pathol Microbiol Scand B (1981) 1.87
Epidemiological patterns of meningococcal disease in Norway 1975-1979. NIPH Ann (1980) 1.86
Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers. Infect Immun (1991) 1.85
Cellular fatty acid composition of Francisella tularensis. J Clin Microbiol (1979) 1.81
Ongoing group B Neisseria meningitidis epidemic in São Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex. J Clin Microbiol (1992) 1.79
Use of single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis. Antimicrob Agents Chemother (1993) 1.77
Some arguments on early hospital admission and treatment of suspected meningococcal disease cases. NIPH Ann (1990) 1.73
Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system. Clin Diagn Lab Immunol (1998) 1.72
Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (1996) 1.71
Rapid serogroup identification of Neisseria meningitidis by using antiserum agar: Prevalence of serotypes in a disease-free military population. J Clin Microbiol (1979) 1.71
Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature. Clin Diagn Lab Immunol (1998) 1.71
Sodium dodecyl sulfate-polyacrylamide gel typing system for characterization of Neisseria meningitidis isolates. J Clin Microbiol (1982) 1.70
Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey. NIPH Ann (1991) 1.68
Statin use is associated with reduced mortality in COPD. Eur Respir J (2006) 1.66
Meningococcal phenotypic and genotypic characteristics and human antibody levels. J Clin Microbiol (1988) 1.65
Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease. Thorax (2011) 1.61
Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerg Infect Dis (2015) 1.61
Role of lipopolysaccharide in wheat germ agglutinin-mediated agglutination of Neisseria meningitidis and Neisseria gonorrhoeae. J Clin Microbiol (1980) 1.60
Differentiation of B15 strains of Neisseria meningitidis by DNA restriction endonuclease fingerprinting. J Infect Dis (1984) 1.59
Class-specific antibody response to group B Neisseria meningitidis capsular polysaccharide: use of polylysine precoating in an enzyme-linked immunosorbent assay. Infect Immun (1982) 1.58
Injectional anthrax in a heroin skin-popper. Lancet (2000) 1.58
Protection against group B meningococcal disease. I. Comparison of group-specific and type-specific protection in the chick embryo model. J Exp Med (1976) 1.56
Role of protein serotype antigens in protection against disease due to Neisseria meningitidis. J Infect Dis (1977) 1.56
Polymerase chain reaction for case ascertainment of meningococcal meningitis: application to the cerebrospinal fluids collected in the course of the Norwegian meningococcal serogroup B protection trial. Scand J Infect Dis (1996) 1.55